Expression of retinoic acid receptor β in dermatofibrosarcoma protuberans

Journal of Cutaneous Pathology

Volumn 36, Issue 11, 2009, Pages 1141-1145

  Xiaoli, Zhou ^a   Qinhe, Fan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; RETINOIC ACID RECEPTOR BETA;

ADULT; ARTICLE; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; CYCLOOXYGENASE 2; DERMATOFIBROSARCOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTORS, RETINOIC ACID; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS; YOUNG ADULT;

EID: 70349511944     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2009.01247.x     Document Type: Article

References (33)

1. De Luca LM. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 1991 5 : 2924.
2. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996 10 : 940.
3. Picard E, Seguin C, Monhoven N, et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst 1999 91 : 989.
4. Widschwendter M, Berger J, Daxenbichler G, et al. Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 1997 57 : 4158.
5. Xu XC, Sozzi G, Lee JS, et al. Suppression of retinoic acid receptor β in nonsmall-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst 1997 89 : 624.
6. Castillo L, Milano G, Santini J, Demard F, Pierrefite V. Analysis of retinoic acid receptor β expression in normal and malignant laryngeal mucosa by a sensitive and routine applicable reverse transcription-polymerase chain reaction enzyme-linked immunosorbent assay method. Clin Cancer Res 1997 3 : 2137.
7. Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). J Natl Cancer Inst 1998 90 : 1529.
8. Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst 1998 90 : 1609.
9. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma, Cancer Res 1998 58 : 4997.
10. Khuri FR, Wu H, Lee JJ, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res 2001 7 : 861.
11. Weiss SW, Goldblum JR. Fibrohistiocytic tumors of intermediate malignancy. In : Weiss SW, Goldblum JR, eds. Soft tissue tumors. St Louis : Mosby, 2001 491.
12. Goldblun JR, Reith JD, Weiss SW. Sarcoma arising in dermatofibrosarcoma ptoruberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up. Am J Surg Pathol 2000 24 : 1125.
13. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998 4 : 844.
14. Dai DL, Martinka M, Li G. Prognostic significance of activated Akt expression inmelanoma: a clinicopathologic study of 292 cases. J Clin Oncol 2005 23 : 1473.
15. Lotan R, Xu XC, Lippman SM, et al. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995 332 : 1405.
16. Qiu HM, Zhang W, El-Naggar AK, et al. Loss of retinoic acid receptor-β expression is an early event during esophageal carcinogenesis. Am J Pathol 1999 155 : 1519.
17. Hida T, Yatabe Y, Achiwa H, et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinoma. Cancer Res 1998 58 : 3761.
18. Murata H, Kawano S, Tsuji S, et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 1999 94 : 451.
19. Dohadwala M, Luo J, Zhu L, et al. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem 2001 276 : 20809.
20. Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000 60 : 1306.
21. Ding XZ, Tong WG, Adrian TE. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res 2000 20 : 2625.
22. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 1997 94 : 3336.
23. Stolina M, Sharma S, Lin Y, et al. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of ILK10 and IL-12 synthesis. J Immunol 2000 164 : 361.
24. Adler N, Tsabari C, Sulkes J, Ad-EI D, Feinmesser M. Cyclooxygenase-2 expression in dermatofibroma and dermatofibrosarcoma protuberans. J Cutan Pathol 2008 35 : 532.
25. Li M, Song S, Lippman SM, et al. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells. Oncogene 2002 21 : 411.
26. Song S, Xu XC. Effect of benzo[a]pyrene diol epoxide on expression of retinoic acid receptor-beta in immortalized esophageal epithelial cells and esophageal cancer cells. Biochem Biophys Res Commun 2001 281 : 872.
27. Tsukamoto H, Hishinuma T, Tayama R, et al. The induction of prostaglandin E synthase and upregulation of cyclooxygenase-2 by 9-cis-retinoic acid. Prostaglandins Other Lipid Mediat 2004 74 : 61.
28. Kong G, Kim HT, Wu K, et al. The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention. Cancer Res 2005 65 : 3462.
29. Jemal A, Tiwari RC, Murray T, et al. American Cancer Society: Cancer statistics. CA Cancer J Clin 2004 54 : 8.
30. Dragnev KH, Rigas JR, Dmitrovsky E. The retinoids and cancer prevention mechanisms. Oncologist 2000 5 : 361.
31. Einspahr JG, Stratton SP, Bowden GT, Alberts DS. Chemoprevention of human skin cancer. Crit Rev Oncol Hematol 2002 41 : 269.
32. Kaiser PC, Korner M, Kappeler A, Aebi S. Retinoid receptors in ovarian cancer: expression and prognosis. Ann Oncol 2005 16 : 1477.
33. Smith W, Saba N. Retinoids as chemoprevention for head and neck cancer: where do we go from here? Crit Rev Oncol Hematol 2005 55 : 143.